ES8504200A1 - Procedimiento para la preparacion de derivados de benzodioxino pirrol. - Google Patents
Procedimiento para la preparacion de derivados de benzodioxino pirrol.Info
- Publication number
- ES8504200A1 ES8504200A1 ES526738A ES526738A ES8504200A1 ES 8504200 A1 ES8504200 A1 ES 8504200A1 ES 526738 A ES526738 A ES 526738A ES 526738 A ES526738 A ES 526738A ES 8504200 A1 ES8504200 A1 ES 8504200A1
- Authority
- ES
- Spain
- Prior art keywords
- compounds
- cycloalkyl
- image
- treatment
- benzodioxinopyrrole
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- CEOQGBDEHVSEQC-UHFFFAOYSA-N 1h-[1,4]benzodioxino[2,3-b]pyrrole Chemical class O1C2=CC=CC=C2OC2=C1NC=C2 CEOQGBDEHVSEQC-UHFFFAOYSA-N 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 4
- 125000006272 (C3-C7) cycloalkyl group Chemical group 0.000 abstract 2
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 1
- 229940104915 Alpha 2 adrenoreceptor antagonist Drugs 0.000 abstract 1
- 208000024827 Alzheimer disease Diseases 0.000 abstract 1
- 206010010774 Constipation Diseases 0.000 abstract 1
- 208000020401 Depressive disease Diseases 0.000 abstract 1
- 206010020772 Hypertension Diseases 0.000 abstract 1
- 206010021333 Ileus paralytic Diseases 0.000 abstract 1
- 201000005081 Intestinal Pseudo-Obstruction Diseases 0.000 abstract 1
- 208000019695 Migraine disease Diseases 0.000 abstract 1
- 208000008589 Obesity Diseases 0.000 abstract 1
- 206010039966 Senile dementia Diseases 0.000 abstract 1
- 208000007536 Thrombosis Diseases 0.000 abstract 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000000304 alkynyl group Chemical group 0.000 abstract 1
- 238000005576 amination reaction Methods 0.000 abstract 1
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 1
- 206010061428 decreased appetite Diseases 0.000 abstract 1
- 206010012601 diabetes mellitus Diseases 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 206010027599 migraine Diseases 0.000 abstract 1
- 230000003880 negative regulation of appetite Effects 0.000 abstract 1
- 235000020824 obesity Nutrition 0.000 abstract 1
- 201000007620 paralytic ileus Diseases 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/056—Ortho-condensed systems with two or more oxygen atoms as ring hetero atoms in the oxygen-containing ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
- C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D317/18—Radicals substituted by singly bound oxygen or sulfur atoms
- C07D317/22—Radicals substituted by singly bound oxygen or sulfur atoms etherified
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
- C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
- C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D319/20—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring with substituents attached to the hetero ring
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Obesity (AREA)
- Cardiology (AREA)
- Emergency Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Heart & Thoracic Surgery (AREA)
- Endocrinology (AREA)
- Anesthesiology (AREA)
- Nutrition Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8230379 | 1982-10-25 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ES526738A0 ES526738A0 (es) | 1985-04-16 |
| ES8504200A1 true ES8504200A1 (es) | 1985-04-16 |
Family
ID=10533819
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES526738A Expired ES8504200A1 (es) | 1982-10-25 | 1983-10-25 | Procedimiento para la preparacion de derivados de benzodioxino pirrol. |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US4496579A (enExample) |
| JP (1) | JPS5998086A (enExample) |
| KR (1) | KR840006486A (enExample) |
| AU (1) | AU2055283A (enExample) |
| BE (1) | BE898072A (enExample) |
| CH (1) | CH661046A5 (enExample) |
| DE (1) | DE3338753A1 (enExample) |
| ES (1) | ES8504200A1 (enExample) |
| FI (1) | FI833887A7 (enExample) |
| FR (1) | FR2534921B1 (enExample) |
| GB (1) | GB2129795B (enExample) |
| GR (1) | GR79405B (enExample) |
| IL (1) | IL70034A0 (enExample) |
| IT (1) | IT1212893B (enExample) |
| LU (1) | LU85059A1 (enExample) |
| NL (1) | NL8303673A (enExample) |
| SE (1) | SE8305866L (enExample) |
| ZA (1) | ZA837921B (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8526210D0 (en) * | 1985-10-23 | 1985-11-27 | Glaxo Group Ltd | Chemical compounds |
| US4769367A (en) * | 1984-04-24 | 1988-09-06 | Glaxo Group Limited | Heterocyclic amino compounds |
| NZ211885A (en) * | 1984-04-24 | 1988-09-29 | Glaxo Group Ltd | Benzodioxinopyrrole derivatives and pharmaceutical compositions containing such |
| GB8410459D0 (en) * | 1984-04-24 | 1984-05-31 | Glaxo Group Ltd | Chemical compounds |
| GB8526209D0 (en) * | 1985-10-23 | 1985-11-27 | Glaxo Group Ltd | Chemical process |
| US5225431A (en) * | 1987-10-23 | 1993-07-06 | Burroughs Wellcome Co. | Therapeutic substituted indole compounds and compositions thereof |
| GB8828032D0 (en) * | 1988-12-01 | 1989-01-05 | Glaxo Group Ltd | Medicaments |
| DE10107243A1 (de) * | 2001-02-16 | 2002-08-22 | Bayer Ag | Benzodioxinopyrrole, deren Herstellung und Verwendung |
| US20070074921A1 (en) * | 2005-09-30 | 2007-04-05 | Coombs Joshua D | Vehicle interface based on a shift of the appendages of a user |
| US8099200B2 (en) * | 2005-09-30 | 2012-01-17 | Coombs Joshua D | Vehicle interface based on the weight distribution of a user |
| US20090076686A1 (en) * | 2005-09-30 | 2009-03-19 | Jeffrey Schox | Vehicle interface to communicate a safety alert mode command |
| US20070074922A1 (en) * | 2005-09-30 | 2007-04-05 | Coombs Joshua D | Vehicle interface based on a shift of the torso of a user |
| US20070078569A1 (en) * | 2005-09-30 | 2007-04-05 | Jeffrey Schox | Vehicle interface to communicate a safety alert mode command |
-
1983
- 1983-10-24 IL IL70034A patent/IL70034A0/xx unknown
- 1983-10-25 IT IT8349214A patent/IT1212893B/it active
- 1983-10-25 ES ES526738A patent/ES8504200A1/es not_active Expired
- 1983-10-25 FR FR8316989A patent/FR2534921B1/fr not_active Expired
- 1983-10-25 GR GR72780A patent/GR79405B/el unknown
- 1983-10-25 GB GB08328468A patent/GB2129795B/en not_active Expired
- 1983-10-25 US US06/545,191 patent/US4496579A/en not_active Expired - Fee Related
- 1983-10-25 BE BE0/211766A patent/BE898072A/fr not_active IP Right Cessation
- 1983-10-25 JP JP58199871A patent/JPS5998086A/ja active Pending
- 1983-10-25 ZA ZA837921A patent/ZA837921B/xx unknown
- 1983-10-25 AU AU20552/83A patent/AU2055283A/en not_active Abandoned
- 1983-10-25 KR KR1019830005035A patent/KR840006486A/ko not_active Withdrawn
- 1983-10-25 SE SE8305866A patent/SE8305866L/xx not_active Application Discontinuation
- 1983-10-25 FI FI833887A patent/FI833887A7/fi not_active Application Discontinuation
- 1983-10-25 DE DE19833338753 patent/DE3338753A1/de not_active Ceased
- 1983-10-25 LU LU85059A patent/LU85059A1/fr unknown
- 1983-10-25 CH CH5771/83A patent/CH661046A5/fr not_active IP Right Cessation
- 1983-10-25 NL NL8303673A patent/NL8303673A/nl not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| LU85059A1 (fr) | 1985-06-19 |
| SE8305866D0 (sv) | 1983-10-25 |
| DE3338753A1 (de) | 1984-04-26 |
| BE898072A (fr) | 1984-04-25 |
| GB2129795B (en) | 1986-02-12 |
| ES526738A0 (es) | 1985-04-16 |
| FI833887A0 (fi) | 1983-10-25 |
| ZA837921B (en) | 1985-04-24 |
| SE8305866L (sv) | 1984-04-26 |
| CH661046A5 (fr) | 1987-06-30 |
| GB2129795A (en) | 1984-05-23 |
| JPS5998086A (ja) | 1984-06-06 |
| KR840006486A (ko) | 1984-11-30 |
| IL70034A0 (en) | 1984-01-31 |
| AU2055283A (en) | 1984-05-03 |
| US4496579A (en) | 1985-01-29 |
| FI833887A7 (fi) | 1984-04-26 |
| IT1212893B (it) | 1989-11-30 |
| FR2534921B1 (fr) | 1987-01-16 |
| IT8349214A0 (it) | 1983-10-25 |
| FR2534921A1 (fr) | 1984-04-27 |
| GB8328468D0 (en) | 1983-11-23 |
| NL8303673A (nl) | 1984-05-16 |
| GR79405B (enExample) | 1984-10-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES8504200A1 (es) | Procedimiento para la preparacion de derivados de benzodioxino pirrol. | |
| AU6690686A (en) | Piperdine derivative and pharmaceutical composition | |
| HUT76476A (en) | Morpholine and thiomorpholine derivatives, process for the preparation thereof and pharmaceutical compositions containing them | |
| HK85690A (en) | Indole derivatives | |
| IL115335A (en) | Naphthyl compounds process for their preparation and pharmaceutical compositions thereof | |
| PT78779A (en) | Process for preparing dihydrobenzopyran derivatives and of pharmaceutical compositions containing the same | |
| BG100154A (en) | Carbazole derivatibes having inhibiting effect to 17,20-lyase | |
| ATE148990T1 (de) | Ebastin oder ebastin-analoga enthaltende arzneimittel | |
| GB2103203A (en) | 1,4-dihydropyridines, their preparation and pharmaceutical compositions containing them | |
| IE56209B1 (en) | Piperidinedione derivatives,processing anti-arrythmic activity,for protecting the myocardium,process for their preparation and pharmaceutical compositions containing said derivatives | |
| EP0272478B1 (en) | Glycyrrhetic acid derivatives and use thereof | |
| US3689504A (en) | N-substituted -alpha-methyl-3,4-(methylenedioxy) phenethylamines | |
| GB1077173A (en) | Substituted alkylene piperidines and methods of preparation thereof | |
| CS402491A3 (en) | Heterocyclic amino compounds, process for their preparation andpharmaceutical compositions containing thereof | |
| DK156064C (da) | Analogifremgangsmaade til fremstilling af 2,4-(1h,3h)-quinazolindionderivater eller farmaceutisk acceptable syreadditionssalte deraf | |
| IL151488A0 (en) | Method for the preparation of citalopram | |
| US3077470A (en) | 3-[4-hydroxy-3-(aminomethyl)-phenyl]-4-(4-oxyphenyl)-alkanes and alkenes | |
| PT99911A (pt) | Processo para a preparacao de 11beta-aril-4-estrenos modificados em posicao 6,7 e de composicoes farmaceuticas que os contem | |
| DK1121109T3 (da) | Tofaset sammensætning med tramadol | |
| ATE8786T1 (de) | Indolobenzoxazinderivate, ihre salze, verfahren zur herstellung, ihre verwendung als arzneimittel und sie enthaltende zusammensetzungen. | |
| UA70961C2 (uk) | ТРИЦИКЛІЧНІ <font face="Symbol">D</font>3-ПІПЕРИДИНИ, КОМПОЗИЦІЯ НА ЇХ ОСНОВІ ТА СПОСІБ ЇХ ОДЕРЖАННЯ (ВАРІАНТИ) | |
| IE820455L (en) | Trifluoromethylphenyltetrahydropyridines having anorectic¹activity | |
| ES482581A1 (es) | Procedimiento para la preparacion de 2-fenilamino-imidazoli-nas-(2) sustituidas. | |
| US3024234A (en) | 4-phenyl-4-alkanoyl-piperidine derivatives | |
| JPS57116052A (en) | Quinazoline derivative and its preparation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD1A | Patent lapsed |
Effective date: 19991108 |